OBJECTIVE: The European Organisation for the Research and Treatment of Cancer
(EORTC) Radiation Oncology Group (ROG) has performed radiotherapy quality assurance …

Quality assurance remains a neglected component of many trials, particularly for technical
interventions, such as surgery and radiotherapy, for which quality of treatment is an …

The European Organization for the Research and Treatment of Cancer (EORTC) is a pan-
European structure charged with improving cancer treatment through the testing of new …

OBJECTIVE: Quality assurance (QA) in clinical trials is essential to ensure treatment is safely
and effectively delivered. As QA requirements have increased in complexity in parallel with …

There is worldwide evidence to justify the inclusion of radiotherapy quality assurance
programmes as an integral part of clinical trial protocols [1e5]. They serve to improve …

Participation in large multi-centre clinical trials aids establishment of the safety and efficacy
of new cancer treatments and methods. Oncology clinical trials have contributed to improved …

Clinical trials have been the center of progress in modern medicine. In oncology, we are
fortunate to have a structure in place through the National Clinical Trials Network (NCTN) …

Purpose To explore site-and clinician-level factors associated with protocol violations
requiring real-time-review (RTR) resubmission in a multicenter clinical trial to help tailor …

The Radiation Therapy Oncology Group (RTOG) designed a random sampling process and
observed its influence upon radiotherapy review mechanisms in cooperative group clinical …

Background Noncompliance with radiotherapy (RT) protocol guidelines has been linked to
inferior clinical outcomes. We performed a meta-analysis of cooperative group trials to …